SQUITTI, ROSANNA
 Distribuzione geografica
Continente #
EU - Europa 4.449
NA - Nord America 646
AS - Asia 394
SA - Sud America 1
Totale 5.490
Nazione #
RU - Federazione Russa 4.145
US - Stati Uniti d'America 636
SG - Singapore 241
DE - Germania 106
TR - Turchia 102
IT - Italia 95
CN - Cina 44
UA - Ucraina 33
SE - Svezia 17
FR - Francia 16
FI - Finlandia 14
CA - Canada 10
GB - Regno Unito 10
IE - Irlanda 4
HK - Hong Kong 3
PL - Polonia 3
AT - Austria 2
TW - Taiwan 2
BE - Belgio 1
BR - Brasile 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
NL - Olanda 1
Totale 5.490
Città #
Moscow 411
The Dalles 170
Chicago 143
Singapore 103
Rome 66
Fairfield 45
Beijing 37
Yubileyny 36
Jacksonville 32
Ashburn 28
Chandler 28
Seattle 26
Houston 23
Cambridge 20
Woodbridge 20
Assago 18
Wilmington 18
Helsinki 10
Ann Arbor 8
Frankfurt am Main 6
Ottawa 6
Salò 5
Turin 5
Boardman 4
Dublin 4
Lawrence 4
New York 4
Princeton 4
Hong Kong 3
Kraków 3
Cedar Knolls 2
London 2
Montreal 2
Nuremberg 2
Prescot 2
San Diego 2
Taichung 2
Toronto 2
Almaty 1
Brussels 1
Elk Grove Village 1
Falkenstein 1
Guangzhou 1
Hebei 1
Hefei 1
Istanbul 1
Leesburg 1
Nanchang 1
Nanjing 1
Oakland 1
Rio de Janeiro 1
Santa Clara 1
Wuhan 1
Totale 1.321
Nome #
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 243
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 189
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 141
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 124
2. Linkage Disequilibrium and haplotype analysis of ATP7B gene in Alzheimer's disease. 57
ATP7B Variants as Modulators of Copper Dyshomeostasis in Alzheimer's Disease 51
Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease 50
ACTIVITIES OF 3'/5' CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES IN THE SUPERIOR CERVICAL-GANGLION OF RAT - CHARACTERIZATION, COMPARTMENTALIZATION AND OBSERVATIONS IN YOUNG AND OLD ANIMALS 49
An observational study on the influence of the APOE-epsilon 4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease 48
Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease 48
Zinc and COVID-19: Basis of Current Clinical Trials 47
A tribute to Tjaard Hoogenraad 47
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 46
Atypical dementia associated with a novel presenilin-2 mutation RID B-1377-2010 46
Prognostic Value of Serum Copper for Post-Stroke Clinical Recovery: A Pilot Study 45
Agricultural Use of Copper and Its Link to Alzheimer's Disease 45
Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: A multicentric study 45
Age dependence of primary motor cortex plasticity induced by paired associative stimulation 45
Antioxidant Status and APOE Genotype As Susceptibility Factors for Neurodegeneration in Alzheimer's Disease and Vascular Dementia 44
METAL DYSFUNCTION AND ALZHEIMER'S DISEASE 44
A case of a mild Wolfram Syndrome with concomitant ATP7B mutation 44
Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease 44
Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration 43
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients RID G-4427-2011 RID B-1377-2010 43
Copper involvement in glutamatergic transmission in physiology and disease as revealed by magnetoencephalography/electroencephalography (MEG/EEG) studies. 42
Copper studies in Alzheimer's disease patients 42
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia 42
Oxidative stress and brain glutamate-mediated excitability in depressed patients 42
Relation of oxidative stress and glycaemic variability with in vivo corneal confocal microscopy parameters in type 1 diabetes 41
Multi-modal factors for recovery prognosis in acute stroke 41
Zinc Therapy in Early Alzheimer's Disease: Safety and Potential Therapeutic Efficacy 41
Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis 41
Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies 41
Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke 40
Effects of axotomy on the expression and ultrastructural localization of N-cadherin and neural cell adhesion molecule in the quail ciliary ganglion: An in vivo model of neuroplasticity 40
Adhesion molecules in the quail ciliary ganglion: An immunocytochemical study after postganglionic nerve crush 40
Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer's Disease and Dementia with Lewy Bodies 40
Ceruloplasmin implication in copper mediated toxicity of Alzheimer's disease 40
Copper and oxidative stress parameters in two monozygotic twins discordant for the degree of cocgnitive impairment 40
Might Diet, APOE-APOA1 Axis, and Iron Metabolism Provide Clues About the Discrepancy in Alzheimer's Disease Occurrence Between Humans and Chimpanzees? A Bioinformatics-Based Re-Analysis of Gene Expression Data on Mice Fed with Human and Chimpanzee Diets 40
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease 40
Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment 40
Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric electroencephalogram study RID E-7602-2010 40
Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer's disease and is decreased by D-penicillamine 40
An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain 40
Low-copper diet as a preventive strategy for Alzheimer's disease 39
Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease 39
Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia. 39
Molecular mechanisms underlying copper function and toxicity in neurons and their possible therapeutic exploitation for Alzheimer's disease 39
Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia 38
Association between sex, systemic iron variation and probability of Parkinson's disease 38
Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology 38
Free Copper Distinguishes Mild Cognitive Impairment Subjects from Healthy Elderly Individuals 38
Iron in Alzheimer's Disease: From Physiology to Disease Disabilities 38
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors 38
Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy 37
Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals 37
Is cognitive function linked to serum free copper levels? A cohort study in a normal population 37
Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease 37
Serum Copper is not Altered in Frontotemporal Lobar Degeneration 37
Viral Loads in Skin Samples of Patients with Monkeypox Virus Infection: A Systematic Review and Meta-Analysis 37
Towards a Unified Vision of Copper Involvement in Alzheimer's Disease: A Review Connecting Basic, Experimental, and Clinical Research 36
Prevalence of mpox viral DNA in cutaneous specimens of monkeypox-infected patients: a systematic review and meta-analysis 36
Structural effects of stabilization and complexation of a zinc-deficient superoxide dismutase 36
GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant 36
Does serum copper and oxidative stress discriminate Alzheimer's disease patients from healthy controls? 36
Genetic Screening of Cystic Fibrosis Transmembrane Regulator (CFTR) in 3,746 Infertile Candidate Couples for Assisted Reproductive Techniques 36
Novel T719P A beta PP Mutation Unbalances the Relative Proportion of Amyloid-beta Peptides 36
Biological factors and age-dependence of primary motor cortex experimental plasticity 36
In silico investigation of the ATP7B gene: insights from functional prediction of non-synonymous substitution to protein structure 35
Duplication of FOXP2 binding sites within CNTNAP2 gene in a girl with neurodevelopmental delay 35
Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II) 35
Intronic rs2147363 Variant in ATP7B Transcription Factor-Binding Site Associated with Alzheimer's Disease 35
A comparison between radiometric and fluorimetric methods for measuring SSAO activity 35
Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease? 35
Copper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variants 35
Elevation of serum copper levels in Alzheimer's disease 35
Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein 35
Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke 35
Alzheimer's Disease and Retinal Degeneration: A Glimpse at Essential Trace Metals in Ocular Fluids and Tissues 35
Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability 35
Excess of serum copper not related to ceruloplasmin in Alzheimer disease 34
Manganese exposure as a determinant of Parkinsonian damage RID E-6702-2010 34
Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases 34
Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimer's Disease 34
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease 34
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease RID B-1377-2010 34
Excess of serum copper not related to ceruloplasmin in Alzheimer disease - Reply from the authors 34
Value of Serum Nonceruloplasmin Copper for Prediction of Mild Cognitive Impairment Conversion to Alzheimer Disease 34
D-penicillamine reduces serum oxidative stress in Alzheimer's disease patients 34
Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease 34
Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer's Disease Patients: How to Measure and Use It 34
Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer's Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia 34
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF beta-amyloid, and h-tau 34
GSTM1 null genotype as risk factor for late-onset Alzheimer's disease in Italian patients 34
Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment 33
Copper phenotype in Alzheimer's disease: dissecting the pathway 33
Elevation of serum copper levels in Alzheimer's disease - Reply 33
Linkage Disequilibrium and Haplotype Analysis of the ATP7B Gene in Alzheimer's Disease 33
Copper in Glucose Intolerance, Cognitive Decline, and Alzheimer Disease 33
Totale 4.436
Categoria #
all - tutte 25.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 0 0 0 0 0 0 0 0 31 16 5
2020/2021115 14 15 4 13 23 8 11 5 3 7 9 3
2021/202221 5 2 4 3 0 0 1 6 0 0 0 0
2022/202371 8 0 0 15 10 16 0 9 8 2 2 1
2023/2024280 2 3 1 3 4 4 2 0 0 0 0 261
2024/20254.854 133 19 1 3 21 353 3.100 950 224 50 0 0
Totale 5.637